CanTx Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
CanTx General Information
Description
Developer of ovarian cancer drug. The company develops drugs which destroys the cancer stem cells.
Contact Information
Website
www.can-tx.comOwnership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
- New Haven, CT
- United States
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
- New Haven, CT
- United States
CanTx Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CanTx Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CanTx FAQs
-
When was CanTx founded?
CanTx was founded in 2013.
-
Where is CanTx headquartered?
CanTx is headquartered in New Haven, CT.
-
What industry is CanTx in?
CanTx’s primary industry is Drug Discovery.
-
Is CanTx a private or public company?
CanTx is a Private company.
-
What is CanTx’s current revenue?
The current revenue for CanTx is .
-
Who are CanTx’s investors?
Kazia Therapeutics and Yale School of Medicine have invested in CanTx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process